Renergen has patented cryogenic cases that can keep vaccines at ultra-cold temperatures for 30 days, a potential way of getting some of the first coronavirus shots to be approved to remote areas.
Ad blocker detected!
Ad blocker detected!
The work we do at TechCentral is made possible through the support of our commercial partners. Please help us produce the original and quality South African technology journalism you value by disabling your ad blocker.
